Interpretation of "Cancer statistics, 2025": A comparative study on cancer epidemiological characteristics and long-term trends between China and the United States
- VernacularTitle:《癌症统计数据2025》解读：中美癌症流行病学特征及长期趋势对比研究
- Author:
Ruifeng XU
1
;
Hongrui WANG
1
;
Yun CHE
1
;
Na REN
1
;
Guochao ZHANG
1
;
Liang ZHAO
1
Author Information
1. Department of Thoracic Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, 100021, P. R. China
- Publication Type:Journal Article
- Keywords:
Cancer statistics;
cancer burden;
long-term trends;
China-US comparison
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2025;32(04):442-452
- CountryChina
- Language:Chinese
-
Abstract:
In 2025, the American Cancer Society published "Cancer statistics, 2025", which projected cancer data for the upcoming year based on incidence data collected by central cancer registries (through 2021) and mortality data obtained from the National Center for Health Statistics (through 2022). Similarly, the National Cancer Center of China released "Cancer incidence and mortality in China, 2022" in December 2024, analyzing data from 22 cancer registries across the country. This study provides a comparative analysis of cancer incidence and mortality trends in China and the United States during the same period, with a focus on sex- and age-specific distributions and long-term changes in cancer patterns. Long-term trends indicate that lung and liver cancer mortality rates in China have declined, primarily due to tobacco control measures and hepatitis B vaccination programs. However, the burden of gastric and esophageal cancers remains substantial. In the United States, mortality rates for colorectal and lung cancers have continued to decline, largely attributed to widespread screening programs and advances in immunotherapy. As economic growth and social development, China’s cancer profile is gradually shifting towards patterns observed in countries with high human development index. However, the prevention and control of upper gastrointestinal cancers remains a critical public health challenge that requires further attention.
